(1 - 18 from 22
)
Aldridge quits Peplin - LabOnline
www.labonline.com.au
US-incorporated biotech Peplin (ASX: PLI) has appointed BIO pioneer Tom Wiggans as CEO, replacing Michael Aldridge. Wiggans, a former ...
Excessive Sweating Treatment Qbrexza Has Been Approved ...
www.natureworldnews.com
... meaningful benefit," Tom Wiggans, chairman and CEO of Dermira, says in a statement, explaining that dermatologists have been telling them ...
In FDA first, Dermira secures approval for excessive sweating ...
www.biopharmadive.com
... primary axillary hyperhidrosis given the stigma and burden associated with this condition," said Dermira CEO Tom Wiggans in a statement.
It's a pivotal moment for Dermira and its acne medication. Can ...
www.statnews.com
SAN FRANCISCO — In a meeting with Dermira (DERM 5) Tuesday, CEO Tom Wiggans and his management team said they're on track to ...
sorted by relevance / date